Search Results

81 results were found

Activity Type CME Provider Title Credit Hours Fee End Date
Reset sort order
JAMA Oncology Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients 1 Yes 3/18/2025
JAMA Oncology Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 1 Yes 10/26/2025
JAMA Oncology Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 1 Yes 10/26/2025
JAMA Oncology Immunotherapy in the Treatment of Localized Genitourinary Cancers 1 Yes 8/10/2026
JAMA Oncology Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer 1 Yes 9/23/2025
JAMA Oncology Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer 1 Yes 9/23/2025
JAMA Oncology Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer - The FAST Multidisciplinary Group Consensus Statement 1 Yes 7/11/2027
JAMA Oncology Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates 1 Yes 12/16/2024
JAMA Oncology Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates - A Review 1 Yes 12/16/2024
JAMA Oncology Left Axilla Adenocarcinoma of Unknown Origin 1 Yes 3/16/2026
JAMA Oncology Left Shoulder Fungating Mass in a 46-Year-Old Man 1 Yes 6/15/2026
JAMA Oncology Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors 1 Yes 4/22/2025
JAMA Oncology Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors 1 Yes 4/22/2025
JAMA Oncology Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors 1 Yes 1/20/2025
JAMA Oncology Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors - A Systematic Review 1 Yes 1/20/2025
JAMA Oncology Management of Down Syndrome Associated Leukemias - A Review 1 Yes 7/13/2025
JAMA Oncology Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes - A Review 1 Yes 5/9/2027
JAMA Oncology Neoadjuvant Immune Checkpoint Inhibitor Therapy for Localized Deficient Mismatch Repair Colorectal Cancer - A Review 1 Yes 9/7/2026
JAMA Oncology Nonhealing Cutaneous Ulcers in a Patient With Myelodysplastic Syndrome 1 Yes 4/13/2026
JAMA Oncology Obstacles to Biosimilar Acceptance and Uptake in Oncology - A Review 1 Yes 5/30/2027